Looking forward to the webinar to see what they say. I'm happy with progress the company is making but with a lot of you would like the sp to be higher. It's a slow road but we're getting there. The quarterly revenue figures were below my 3.2m but that's in the past now.
Forward looking statements are good! Cc forecast to grow in sales, infusion products sales seen increasing , costs to decrease in December qtr and hsv2 results around the corner. Just need a cornerstone investor to start buying up
AHZ Price at posting:
6.3¢ Sentiment: Hold Disclosure: Held
